E-LIB Suche - Ergebnisse für: Mesa, R

1

PCR81 Diagnosis and Treatment Patterns in European Patients..:

Triggiani, M. ; Mesa, R. ; Hobart, J....
Value in Health. 26 (2023) 12 - p. S464 , 2023

Link: https://doi.org/10.1016/..

2

CO96 Myelofibrosis Symptom Assessment Form Total Symptom Sc..:

Daskalopoulou, C. ; Gorsh, B. ; Dumi, G....
Value in Health. 26 (2023) 12 - p. S31-S32 , 2023

Link: https://doi.org/10.1016/..

3

PCR136 The Burden of Systemic Mastocytosis in Select Europe..:

Mesa, R. ; Triggiani, M. ; Hobart, J....
Value in Health. 26 (2023) 12 - p. S475 , 2023

Link: https://doi.org/10.1016/..

4

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOU..:

Vannucchi, A. ; Mesa, R. ; Gerds, A....
HemaSphere. 6 (2022) - p. 940-941 , 2022

Link: https://doi.org/10.1097/..

5

P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBRO..:

Kiladjian, J.-J. ; Tefferi, A. ; Passamonti, F....
HemaSphere. 6 (2022) - p. 931-932 , 2022

Link: https://doi.org/10.1097/..

6

P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENT..:

Gill, H. ; Yacoub, A. ; Pettit, K....
HemaSphere. 6 (2022) - p. 941-942 , 2022

Link: https://doi.org/10.1097/..

7

POS-286 KDIGO RISK AND ITS INFLUENCE ON THE ASSOCIATION BET..:

ELFASSY, T. ; Tremblay, J. ; Nahodyl, L....
Kidney International Reports. 7 (2022) 2 - p. S127-S128 , 2022

Link: https://doi.org/10.1016/..

8

P1042: SAFETY AND TOLERABILITY RESULTS FROM THE PHASE 3B FR..:

Gupta, V. ; Yacoub, A. ; Verstovsek, S....
HemaSphere. 6 (2022) - p. 932-933 , 2022

Link: https://doi.org/10.1097/..

9

P1037: DOES EARLY INTERVENTION IN MYELOFIBROSIS IMPACT OUTC..:

Harrison, C. ; Kiladjian, J.-J. ; Vannucchi, A. M....
HemaSphere. 6 (2022) - p. 927-928 , 2022

Link: https://doi.org/10.1097/..

10

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACR..:

Harrison, C. ; Bose, P. ; Mesa, R....
HemaSphere. 6 (2022) - p. 959-960 , 2022

Link: https://doi.org/10.1097/..

11

P1068: RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIE..:

Vannucchi, A. ; Pemmaraju, N. ; Scott, B....
HemaSphere. 6 (2022) - p. 958-959 , 2022

Link: https://doi.org/10.1097/..

12

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BL..:

Harrison, C. ; Rampal, R. K. ; Gupta, V....
HemaSphere. 6 (2022) - p. 920-921 , 2022

Link: https://doi.org/10.1097/..

13

P1062: A REAL-WORLD EVALUATION OF THE ASSOCIATION BETWEEN E..:

Gerds, A. T. ; Mesa, R. ; Burke, J. M....
HemaSphere. 6 (2022) - p. 952-953 , 2022

Link: https://doi.org/10.1097/..

14

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MM..:

Verstovsek, S. ; Vannucchi, A. ; Gerds, A....
HemaSphere. 6 (2022) - p. 96-97 , 2022

Link: https://doi.org/10.1097/..

15

Evaluation of Patient and Staff Safety Through Continuous D..:

Asper, J. ; Viles, J. ; Fakhreddine, M....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e497 , 2021

Link: https://doi.org/10.1016/..